Passage Bio, Inc. (PASG) Tops Q2 EPS by 5c

Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.26), $0.05 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• JPMorgan Upgrades Nanya Technology Corp (2408:TT) to Overweight
• Correction: Kepler Cheuvreux Upgrades Siemens AG (SIE:GR) (SIEGY) to Hold